comparisons were made between the responses of o. gutturosa and brugia pahangi to certain drugs and these species were found to significantly differ in their sensitivities to ivermectin and a novel compound ( wellcome ) , indicating that onchocerca parasites should be used wherever possible for compound identification and development intended for the treatment of onchocerciasis .
C0022322
ivermectin
C0029001
onchocerciasis